Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125364902 | 12536490 | 2 | F | 20160509 | 20160913 | 20160707 | 20160913 | PER | US-PFIZER INC-2016306337 | PFIZER | 74.00 | YR | F | Y | 0.00000 | 20160913 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125364902 | 12536490 | 1 | PS | SILDENAFIL CITRATE. | SILDENAFIL CITRATE | 1 | UNK | U | 21845 | FILM-COATED TABLET | |||||||||
| 125364902 | 12536490 | 2 | SS | ORENITRAM | TREPROSTINIL | 1 | Oral | 1 MG, 3X/DAY | 0 | 1 | MG | TABLET | TID | ||||||
| 125364902 | 12536490 | 3 | SS | ORENITRAM | TREPROSTINIL | 1 | Oral | 0.625 MG, 3X/DAY | 0 | .625 | MG | TABLET | TID | ||||||
| 125364902 | 12536490 | 4 | SS | ORENITRAM | TREPROSTINIL | 1 | Oral | 1 MG, 3X/DAY | 0 | 1 | MG | TABLET | TID | ||||||
| 125364902 | 12536490 | 5 | SS | ORENITRAM | TREPROSTINIL | 1 | Oral | 0.125 MG, 3X/DAY | 0 | .125 | MG | TABLET | TID | ||||||
| 125364902 | 12536490 | 6 | SS | AMBRISENTAN | AMBRISENTAN | 1 | 5 MG, 1X/DAY | U | 1412805A | 0 | 5 | MG | TABLET | QD | |||||
| 125364902 | 12536490 | 7 | SS | AMBRISENTAN | AMBRISENTAN | 1 | 5 MG, 2X/DAY | U | 1412805A | 0 | 5 | MG | TABLET | BID | |||||
| 125364902 | 12536490 | 8 | C | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | UNK | 0 | |||||||||||
| 125364902 | 12536490 | 9 | C | AZATHIOPRINE. | AZATHIOPRINE | 1 | UNK | 0 | |||||||||||
| 125364902 | 12536490 | 10 | C | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | UNK | 0 | |||||||||||
| 125364902 | 12536490 | 11 | C | BUMETANIDE. | BUMETANIDE | 1 | UNK | 0 | |||||||||||
| 125364902 | 12536490 | 12 | C | POTASSIUM | POTASSIUM | 1 | UNK | 0 | |||||||||||
| 125364902 | 12536490 | 13 | C | METOPROLOL SUCCINATE. | METOPROLOL SUCCINATE | 1 | UNK | 0 | |||||||||||
| 125364902 | 12536490 | 14 | C | LEVOTHYROXINE SODIUM. | LEVOTHYROXINE SODIUM | 1 | UNK | 0 | |||||||||||
| 125364902 | 12536490 | 15 | C | LASIX | FUROSEMIDE | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125364902 | 12536490 | 2 | Pulmonary arterial hypertension |
| 125364902 | 12536490 | 3 | Pulmonary hypertension |
| 125364902 | 12536490 | 6 | Pulmonary hypertension |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125364902 | 12536490 | Abdominal discomfort | |
| 125364902 | 12536490 | Abdominal pain upper | |
| 125364902 | 12536490 | Diarrhoea | |
| 125364902 | 12536490 | Dyspepsia | |
| 125364902 | 12536490 | Fatigue | |
| 125364902 | 12536490 | Headache | |
| 125364902 | 12536490 | Swelling |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125364902 | 12536490 | 2 | 20160425 | 0 | ||
| 125364902 | 12536490 | 3 | 20160426 | 0 | ||
| 125364902 | 12536490 | 4 | 20160426 | 0 | ||
| 125364902 | 12536490 | 5 | 20160506 | 0 | ||
| 125364902 | 12536490 | 6 | 20140820 | 0 | ||
| 125364902 | 12536490 | 7 | 20150416 | 0 |